Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cellegy Pharmaceuticals Announces Public Offering of 2.25 Million Shares of Common Stock.


FOSTER CITY, Calif.--(BW HealthWire)--Oct. 20, 1997--Cellegy Pharmaceuticals Inc. (Nasdaq Small Cap:CLGY) announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission with respect to a proposed offering of 2.25 million shares of its common stock.

Oppenheimer Op·pen·hei·mer   , J(ulius) Robert 1902-1967.

American physicist who directed the Los Alamos, New Mexico, laboratory during the development of the first atomic bomb (1942-1945).

Noun 1.
 & Co. Inc. is acting as underwriter underwriter n. a company or person which/who underwrites an insurance policy, issue of corporate securities, business, or project. (See: underwrite)


UNDERWRITER, insurances. One who signs a policy of insurance, by which he becomes an insurer.
 in connection with the offering.

A registration statement relating to relating to relate prepconcernant

relating to relate prepbezüglich +gen, mit Bezug auf +acc 
 these secuany sales of these securities in any state in prospectus. A copy of the preliminary prospectus Preliminary Prospectus

A first draft registration statement filed by a firm prior to proceeding with an initial public offering of securities. The document, filed with the Securities & Exchange Commission, is intended to provide pertinent information to prospective shareholders
 may be obtained from: Oppenheimer & Co. Inc., Oppenheimer Tower, One World Financial Center, 200 Liberty St., 39thOTECHNOLOGY
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Oct 20, 1997
Words:97
Previous Article:Smartor Products Inc. Signs Joint Venture Agreement.
Next Article:Symposium Makes the Grade with Stanford University.
Topics:



Related Articles
Neose Technologies Announces Underwriters Exercise Overallotment Option.
Cellegy Pharmaceuticals announces the appointment of Coffin Communications Group as investor-relations agent.
Cellegy Pharmaceuticals reports first quarter financial results.
Cellegy Pharmaceuticals Completes a $3.8 Million Private Placement and Reacquires Rights to Patented Skin Repair Technology.
Cellegy Pharmaceuticals Announces Public Offering of Common Stock.
PharmaPrint Completes $23.6 Million Public Offering.
MARKET REACTION NOT POSITIVE TO MINIMED DISTRIBUTION DEALS.
Altus Pharmaceuticals Announces Pricing of its Initial Public Offering.
Valera Pharmaceuticals Announces the Pricing of Its Initial Public Offering.
Valera Pharmaceuticals Announces Closing of Initial Public Offering.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles